1.
纳入的NSCLC EGFR突变研究
Eligible studies for EGFR mutation of NSCLC
| EGFR mutation | Pairs | Primary NSCLC | Metastases | Inconsistency | |||||
| n | Percent | n | Percent | n | Percent | ||||
| Matsumoto S[17] | 19 | 6 | 31.58% | 12 | 63.16% | 11 | 57.89% | ||
| Cortot AB[18] | 21 | 0 | 0.00% | 0 | 0.00% | 0 | 0% | ||
| Kalikaki A[19] | 25 | 5 | 20.00% | 3 | 12.00% | 6 | 24.00% | ||
| Daniele L[15] | 28 | 0 | 0.00% | 0 | 0.00% | 0 | 0% | ||
| Gow CH[20] | 67 | 18 | 26.87% | 26 | 38.81% | 26 | 38.81% | ||
| Park S[21] | 101 | 30 | 29.70% | 28 | 27.72% | 12 | 11.88% | ||
| Schmid K[22] | 96 | 4 | 4.17% | 4 | 4.17% | 6 | 6.25% | ||
| Sum | 357 | 63 | 17.17% | 73 | 19.89% | 61 | 17.09% | ||